LH LabcorpcompanySEC Filings & Insider Trading Activity 2026
Latest Labcorp (LH) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 24, 2026, a 10-Q quarterly report filed on October 31, 2025, an 8-K current report filed on April 30, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Labcorp (LH) (SEC CIK 920148), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Management Discussion & Analysis
- • Revenue $13,951.7 in FY2025, up 7.2% YoY from $13,008.9; driven by 4.4% organic growth, 2.5% acquisitions net of divestitures, 0.4% FX tailwind
- • Operating margin 9.9% vs 8.4% YoY; cost of revenues fell to 71.2% vs 72.1%; SG&A fell to 15.9% vs 17.1% of revenue
Business Overview
- • Dual-segment lab services platform: Dx (clinical testing, $10.9B revenue) and BLS (drug development services, $3.1B revenue), total revenues $13.95B
- • New specialty test launches in 2025: Alzheimer's disease diagnostics, molecular residual disease detection, expanded oncology precision testing; also nationwide self-collection HPV/STI testing via Labcorp OnDemand
Risk Factors
- • Ravgen patent verdict: $272M jury award + $100M enhanced damages + $2.6M supplemental + $100/test ongoing royalty through patent life
- • PAMA Medicare reimbursement cuts frozen 2026, resuming 2027–2029 capped at 15%/year with further reductions possible thereafter
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-09-30)
Risk Factors
- • No material changes in risk factors from 2024 10-K carried forward
- • Pandemic impact risk persists with potential lab test volume fluctuations
Management Discussion & Analysis
- • Revenue $3.56B Q3 FY25, up 8.6% YoY from $3.28B; organic growth 6.2%, acquisitions 1.7%, currency 0.7%
- • Operating margin Q3 FY25: Dx 16.3% vs 15.2% YoY, BLS 16.5% vs 16.4% YoY; total operating income $396.6M up 56.1% YoY
Annual Reports Archive10-K
AI-powered analysis of Labcorp (LH) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of Labcorp (LH) 10-Q quarterly reports filed with SEC EDGAR.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | — | $12.2B | $13.0B | $14.0B |
| Gross Profit | $4.4B | $3.4B | $3.6B | $4.0B |
| Operating Income | — | $725.6M | $1.1B | $1.4B |
| Net Income | — | $418.0M | $746.0M | $876.5M |
| Gross Margin | — | 27.7% | 27.9% | 28.8% |
| Op. Margin | — | 6.0% | 8.4% | 9.9% |
| Net Margin | — | 3.4% | 5.7% | 6.3% |
| Balance Sheet | ||||
| Total Assets | $20.2B | $16.7B | $18.4B | $18.4B |
| Equity | — | $7.9B | $8.1B | $8.6B |
| ROE | — | 5.3% | 9.3% | 10.2% |
Source: XBRL financial data from Labcorp (LH) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 30, 2026 | — | — | — |
8-K | Apr 9, 2026 | — | — | — |
8-K | Mar 31, 2026 | — | — | — |
8-K | Mar 20, 2026 | — | — | — |
10-K | Feb 24, 2026 | Dec 31, 2025 | Analysis | |
8-K | Feb 17, 2026 | — | — | |
8-K | Feb 9, 2026 | — | — | |
8-K | Jan 29, 2026 | — | — | |
8-K | Jan 15, 2026 | — | — | |
8-K | Jan 14, 2026 | — | — | |
8-K | Dec 30, 2025 | — | — | |
8-K | Dec 15, 2025 | — | — | |
8-K | Dec 10, 2025 | — | — | |
8-K | Nov 24, 2025 | — | — | |
10-Q | Oct 31, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Aug 1, 2025 | Jun 30, 2025 | — | |
10-Q | Apr 29, 2025 | Mar 31, 2025 | — | |
10-K | Feb 25, 2025 | Dec 31, 2024 | Analysis | |
10-Q | Oct 29, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 2, 2024 | Jun 30, 2024 | — | |
10-Q | Apr 30, 2024 | Mar 31, 2024 | — | |
10-K | Feb 26, 2024 | Dec 31, 2023 | — | |
10-Q | Oct 30, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 4, 2023 | Jun 30, 2023 | — | |
10-Q | May 4, 2023 | Mar 31, 2023 | — |
Frequently Asked Questions
What are the latest LH SEC filings in 2026?
Labcorp (LH) has filed a 10-K annual report on February 24, 2026, a 10-Q quarterly report on October 31, 2025, an 8-K current report on April 30, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did LH file its most recent 10-K annual report?
Labcorp (LH) filed its most recent 10-K annual report on February 24, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view LH 10-Q quarterly reports?
Labcorp (LH)'s most recent 10-Q quarterly report was filed on October 31, 2025. SignalX displays every LH 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has LH filed recently?
Labcorp (LH)'s most recent 8-K was filed on April 30, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find LH insider trading activity (Form 4)?
SignalX aggregates every LH Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does LH file with the SEC?
Labcorp (LH) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new LH filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Labcorp (LH).
What is LH's SEC CIK number?
Labcorp (LH)'s SEC CIK (Central Index Key) number is 920148. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 920148 to look up all LH filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find LH return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Labcorp (LH) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Labcorp SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 45+ filings.